Northwestern Mutual Wealth Management
KRYS icon

Northwestern Mutual Wealth Management’s Krystal Biotech KRYS Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-13
Closed -$3.36K – 4297
2026
Q1 		$3.36K Buy
+13
New +$3.46K ﹤0.01% 3436
2024
Q1 		– Sell
-52
Closed -$6.45K – 3697
2023
Q4 		$6.45K Buy
+52
New +$5.77K ﹤0.01% 2784
2023
Q2 		– Sell
-5
Closed -$400 – 3485
2023
Q1 		$400 Buy
+5
New +$393 ﹤0.01% 3129

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Northwestern Mutual Wealth Management's KRYS Position: Q2 2026 in Review

Northwestern Mutual Wealth Management sold out of Krystal Biotech (KRYS) in Q2 2026, closing a stake of 13 shares — an estimated $3.36K sold.

Northwestern Mutual Wealth Management first reported a position in KRYS in Q1 2023 and held it in 3 quarters. The position peaked at $6.45K in Q4 2023. 423 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Northwestern Mutual Wealth Management reported no remaining Krystal Biotech position as of Q2 2026 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 13 Krystal Biotech shares in Q2 2026, an estimated $3.36K.
  • Northwestern Mutual Wealth Management first reported a position in Krystal Biotech in Q1 2023 and held it in 3 quarters.
  • Northwestern Mutual Wealth Management's Krystal Biotech position peaked at $6.45K in Q4 2023.
  • 423 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.